À retenir
In a randomised trial of 207 people with hypertension (68.2 years, 76.8% women), a 9-month supervised walking programme of 120 min/week lowered systolic blood pressure by 8.68 mm Hg and cardiovascular risk score by 1.19 points in multivariate models. The trial was registered retrospectively and the abstract gives no confidence intervals, so the precision of the effect is unknown.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Physical activity supports cardiovascular health and health-related quality of life, but its effect on blood pressure control in people who already have hypertension has rarely been studied. The authors tested whether a structured physical activity programme changes cardiovascular risk, quality of life and blood pressure control in hypertensive adults.
Population et méthode
Randomised clinical trial of a 9-month physical activity programme: a supervised walking group of 120 min/week combined with socio-cultural activities, in 207 hypertensive primary care users (68.2 years, 76.8% women). Physical activity (IPAQ-s questionnaire), diet, cardiovascular disease (CVD) risk, blood pressure, BMI, smoking and health-related quality of life (HRQoL, measured with the SF-36) were assessed at baseline and at the end of the programme. Changes in CVD risk and HRQoL were calculated as end score minus baseline score, and multivariate models were applied. The abstract does not describe what the comparison group did.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1In multivariate models, the programme, with no change to diet, lowered the CVD risk score by 1.19 points and systolic blood pressure by 8.68 mm Hg.
- 2Some areas of quality of life improved, by 4.45 to 14.62 points.
- 3The programme itself was linked to a higher share of people with controlled blood pressure (OR 5.395 to 5.785, depending on the multivariate model).
- 4Decreases in CVD risk during the programme (OR 0.609) and increases in the SF-36 physical component summary (OR 1.041), role physical (OR 1.010) and bodily pain (OR 1.014) scores were each also linked to controlled blood pressure, independent of whether pressure was controlled at baseline.
Limites et incertitude
- 1The trial was registered retrospectively (5 May 2016), so planned outcomes could not be checked against a registration made in advance.
- 2The abstract does not say how people were allocated or what the comparison group did, and it reports no confidence intervals or P values, so the precision of the effects is unclear.
- 3The walking group was supervised and included socio-cultural activities, so any benefit may come from the whole package rather than walking alone; participants were mostly women aged 68.2 years.
- 4Outcomes were measured only at baseline and at the end of 9 months, so the abstract cannot show whether benefits last. This reading is based on the abstract only.
Mise en perspective
A supervised group walking routine of 120 min/week over 9 months was followed by lower systolic pressure and better quality-of-life scores in people with hypertension. Because the abstract lacks confidence intervals and a described comparison group, treat 8.68 mm Hg as what happened in this trial, not what you will get. Anyone with hypertension should check an exercise plan with their clinician first.
Vos données
A home blood pressure cuff and a step counter or watch can mirror this trial. Log your weekly walking minutes against the 120 min/week target, and compare weekly average blood pressure (seated, rested, same time of day) over several months rather than single readings. Share the trend with your clinician, who decides whether any treatment needs adjusting.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Physical activity (PA) promotes cardiovascular health and health related quality of life (HRQoL), although the effect of that on blood pressure (BP) control has rarely been studied in hypertensive subjects. Our aim was to evaluate the effectiveness of a PA intervention programme on cardiovascular disease (CVD) risk, HRQoL and BP control in hypertensive subjects.
Methods
A randomized clinical trial, with a PA intervention programme of 9 months duration, comprising a walking group of 120 min/week, supervised, and with socio-cultural activities. Participants were 207 hypertensive subjects (68.2 years, 76.8% women). PA (IPAQ-s), diet, CVD risk, BP, BMI, smoking, and HRQoL (SF-36) were assessed at baseline and at the end of the intervention. Changes in CVD risk and in HRQoL during the intervention was calculated (end-baseline score). Multivariate models were applied.
Results
In multivariate models, the PA intervention programme, with no modification of the diet, decreased CVD risk (- 1.19 points) and the systolic BP (- 8.68 mmHg), and increased some areas of HRQoL (4.45 to 14.62 points). An increase in the percentage of subjects with controlled BP was observed by the PA programme itself (OR 5.395 to 5.785 according to multivariate models), and by the changes during the intervention in the decrease in CVD risk (OR 0.609) and in the increase in the HRQoL in physical component summary (OR 1.041), role physical (OR 1.010), and bodily pain (OR 1.014), independently of controlled BP at baseline.
Conclusions
This PA intervention programme improved cardiovascular health and HRQoL, and favoured BP control in primary care users with hypertension.
Trial registration
Clinicaltrials.gov ID NCT02767739 ; Trial registered on May 5th, 2016. Retrospectively registered.
Sources et attribution
Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial.
Arija V, Villalobos F, Pedret R, Vinuesa A, Jovani D, Pascual G, Basora J.
Health and quality of life outcomes · 2018-09-14
DOI: 10.1186/s12955-018-1008-6 ↗PubMed · 30217193 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

